- Home
- SMTI vs CERS Comparison
SMTI vs CERS Comparison
Compare SMTI & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- CERS
- Stock Information
- Founded
- SMTI 1982
- CERS 1991
- Country
- SMTI United States
- CERS United States
- Employees
- SMTI N/A
- CERS N/A
- Industry
- SMTI Medical/Dental Instruments
- CERS EDP Services
- Sector
- SMTI Health Care
- CERS Technology
- Exchange
- SMTI Nasdaq
- CERS Nasdaq
- Market Cap
- SMTI 288.2M
- CERS 324.3M
- IPO Year
- SMTI N/A
- CERS 1997
- Fundamental
- Price
- SMTI $36.90
- CERS $1.70
- Analyst Decision
- SMTI Buy
- CERS Buy
- Analyst Count
- SMTI 1
- CERS 3
- Target Price
- SMTI $44.00
- CERS $3.17
- AVG Volume (30 Days)
- SMTI 29.7K
- CERS 1.9M
- Earning Date
- SMTI 11-12-2024
- CERS 10-30-2024
- Dividend Yield
- SMTI N/A
- CERS N/A
- EPS Growth
- SMTI N/A
- CERS N/A
- EPS
- SMTI N/A
- CERS N/A
- Revenue
- SMTI $78,056,873.00
- CERS $176,229,000.00
- Revenue This Year
- SMTI $26.97
- CERS $26.47
- Revenue Next Year
- SMTI $18.91
- CERS $11.48
- P/E Ratio
- SMTI N/A
- CERS N/A
- Revenue Growth
- SMTI 24.66
- CERS 14.71
- 52 Week Low
- SMTI $26.00
- CERS $1.38
- 52 Week High
- SMTI $43.25
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- SMTI 63.48
- CERS 46.20
- Support Level
- SMTI $33.50
- CERS $1.63
- Resistance Level
- SMTI $38.22
- CERS $2.03
- Average True Range (ATR)
- SMTI 2.00
- CERS 0.11
- MACD
- SMTI 0.24
- CERS -0.01
- Stochastic Oscillator
- SMTI 75.47
- CERS 31.37
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.